Bevacizumab (Avastin) as a surgical adjunct in diabetic vitrectomy for fibrovascular disease

Eye

Volumn 23, Issue 3, 2009, Pages 742-743

  Gandhi, J S ^a   Tan, L T ^a   Pearce, I ^b   Charles, S J ^a  

^a MANCHESTER ROYAL EYE HOSPITAL   (United Kingdom)

^b ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; ANGIOGENESIS INHIBITOR; MONOCLONAL ANTIBODY;

ADULT; CASE REPORT; DIABETIC RETINOPATHY; DISEASE SEVERITY; HUMAN; LETTER; PHOTOGRAPHY; PREOPERATIVE PERIOD; VISUAL ACUITY; VITRECTOMY; ADJUVANT CHEMOTHERAPY; CHEMICALLY INDUCED; COMPLICATION; INSULIN DEPENDENT DIABETES MELLITUS; RETINA TEAR;

ADULT; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL; ANTIBODIES, MONOCLONAL, HUMANIZED; CHEMOTHERAPY, ADJUVANT; DIABETES MELLITUS, TYPE 1; DIABETIC RETINOPATHY; HUMANS; RETINAL PERFORATIONS; VITRECTOMY;

EID: 62549148148     PISSN: 0950222X     EISSN: 14765454     Source Type: Journal    
DOI: 10.1038/eye.2008.99     Document Type: Letter

References (5)

1. Rosenfeld PJ, Moshfeghi AA, Puliafito CA. Optical coherence tomography findings after an intravitreal injection of bevacizumab (Avastin) for neovascular age-related macular degeneration. Ophthalmic Surg Lasers Imaging 2005; 35: 331-335.
2. Rosenfeld PJ, Fung AR, Puliafito CA. Optical coherence tomography findings after an intravitreal injection of bevacizumab (Avastin) for macular oedema from central retinal vein occlusion. Ophthalmic Surg Lasers Imaging 2005; 36: 336-339.
3. Avery RL, Pearlman J, Pieramici DJ, Rabena MD, Castellarin AA, Nasir MA et al. Intravitreal bevacizumab (Avastin) in the treatment of proliferative diabetic retinopathy. Ophthalmology 2006; 113: 1695-1705.
4. Chen E, Park C. Use of intravitreal bevacizumab as a preoperative adjunct for tractional retinal detachment repair in severe proliferative diabetic retinopathy. Retina 2006; 26: 699-700.
5. Mason JO, Nixon PA, White MF. Intravitreal injection of bevacizumab (Avastin) as adjunctive treatment of proliferative diabetic retinopathy. Am J Ophthal 2006; 142: 685-688.